These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 17083723

  • 1. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA, Strieter RM.
    Mol Cancer; 2006 Nov 03; 5():56. PubMed ID: 17083723
    [Abstract] [Full Text] [Related]

  • 2. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J, Semenza GL.
    Cancer Res; 2005 Jul 15; 65(14):6178-88. PubMed ID: 16024619
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
    Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM.
    Am J Respir Crit Care Med; 2003 Jun 15; 167(12):1676-86. PubMed ID: 12626353
    [Abstract] [Full Text] [Related]

  • 5. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
    Wang L, Huang T, Chen W, Gao X, Zhou T, Wu Z, Sun Y.
    Oncol Rep; 2012 Dec 15; 28(6):2043-8. PubMed ID: 22972438
    [Abstract] [Full Text] [Related]

  • 6. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B, Schendel DJ, Zimmermann W, Pohla H.
    Stem Cells; 2013 Aug 15; 31(8):1467-76. PubMed ID: 23630186
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.
    Shang D, Liu Y, Yang P, Chen Y, Tian Y.
    Urology; 2012 Apr 15; 79(4):966.e1-7. PubMed ID: 22341602
    [Abstract] [Full Text] [Related]

  • 11. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA, Ashcroft M.
    Cancer Res; 2006 Jun 15; 66(12):6264-70. PubMed ID: 16778202
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY, Poellinger L, Walker CL.
    Cancer Res; 2003 May 15; 63(10):2675-80. PubMed ID: 12750296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X, Shen D, Huang Y, Yin C, Bojanowski CM, Zhuang Z, Chan CC.
    Ophthalmology; 2007 Jan 15; 114(1):147-56. PubMed ID: 17070589
    [Abstract] [Full Text] [Related]

  • 16. Role of HIF-1alpha in proton-mediated CXCR4 down-regulation in endothelial cells.
    Melchionna R, Romani M, Ambrosino V, D'Arcangelo D, Cencioni C, Porcelli D, Toietta G, Truffa S, Gaetano C, Mangoni A, Pozzoli O, Cappuzzello C, Capogrossi MC, Napolitano M.
    Cardiovasc Res; 2010 May 01; 86(2):293-301. PubMed ID: 20007689
    [Abstract] [Full Text] [Related]

  • 17. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
    Thompson JM, Nguyen QH, Singh M, Pavesic MW, Nesterenko I, Nelson LJ, Liao AC, Razorenova OV.
    Oncogene; 2017 Feb 23; 36(8):1080-1089. PubMed ID: 27841867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H, Matsubara A, Teishima J, Mutaguchi K, Yasumoto H, Dahiya R, Usui T, Kamiya K.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):656-63. PubMed ID: 15240098
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.